Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway (Q30441092)

21 June 2017

Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway (English)

1 reference

21 June 2017

1 reference

Amorino GP

1

1 reference

21 June 2017

Deeble PD

series ordinal

2

1 reference

21 June 2017

Parsons SJ

series ordinal

3

1 reference

21 June 2017

language of work or name

English

0 references

publication date

24 July 2006

1 reference

21 June 2017

1 reference

21 June 2017

26

1 reference

21 June 2017

745-756

1 reference

21 June 2017

5

1 reference

Neuroendocrine differentiation in prostatic carcinoma

21 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Neuroendocrine cells in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Signal characteristics of G protein-transactivated EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Novel activation of STAT5b in response to epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Tyrosine kinase inhibition: an approach to drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Src tyrosine kinase is a novel direct effector of G proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Transactivation of epidermal growth factor receptor after heparin‐binding epidermal growth factor‐like growth factor shedding in the migration of prostate cancer cells promoted by bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Mutations in the catalytic subunit of cAMP-dependent protein kinase result in unregulated biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Neuropeptide receptor status in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Mechanism of biological synergy between cellular Src and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Identification of sites on epidermal growth factor receptors which are phosphorylated by pp60src in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Activation of extracellular signal-regulated kinase mediates bombesin-induced mitogenic responses in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

Bombesin stimulates growth of human prostatic cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

inferred from DOI database lookup

7 January 2021

based on heuristic

[Effect of the neuropeptides bombesin and calcitonin on the growth of prostate cell lines, PC-3, DU 145, and LNCaP]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

inferred from DOI database lookup

7 January 2021

based on heuristic

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209814

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1209814

1 reference

Dimensions Publication ID

21 June 2017

0 references

1 reference